Brandon Holtrup
Investitore di Private Equity presso Oberland Capital Management LLC
Profilo
Dr. Holtrup is a Vice President at Oberland Capital.
Prior to joining Oberland, Dr. Holtrup was an Associate Director in Global Analytics & Insight (Early Oncology) at AstraZeneca, where he focused on evaluating the commercial potential of early-stage assets.
Previously, Dr. Holtrup was a Consultant at L.E.K.
Consulting, where he provided strategic management advising to pharmaceutical and biotech companies.
Dr. Holtrup completed a PhD at Yale University, focusing on the molecular mechanisms governing metabolism and obesity.
Dr. Holtrup also holds a B.S.
from DePaul University in Biology.
Posizioni attive di Brandon Holtrup
| Società | Posizione | Inizio |
|---|---|---|
Oberland Capital Management LLC
 Oberland Capital Management LLC Investment ManagersFinance Oberland Capital Management LLC (Oberland Capital) is a private equity firm founded in 2013 by Jean-Pierre Naegeli and Andrew Rubinstein. The firm is headquartered in New York. | Investitore di Private Equity | 01/02/2023 |
Formazione di Brandon Holtrup
| Yale University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Oberland Capital Management LLC
Oberland Capital Management LLC Investment ManagersFinance Oberland Capital Management LLC (Oberland Capital) is a private equity firm founded in 2013 by Jean-Pierre Naegeli and Andrew Rubinstein. The firm is headquartered in New York. | Finance |
- Borsa valori
- Insiders
- Brandon Holtrup
